Turkey is a leading destination for rectal cancer treatment, with top facilities accredited by the Joint Commission International. Anadolu Medical Center, Memorial Şişli Hospital, and Hisar Hospital Intercontinental are among the leading institutions offering advanced treatments. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is particularly noted for providing American-standard care, while Memorial Şişli Hospital, Turkey's first JCI-accredited hospital, boasts a 90% success rate in organ transplants. Hisar Hospital Intercontinental is also widely recognized for its excellence in oncology.
Innovative procedures available in Turkey include minimally invasive surgery, robotic-assisted surgery, targeted therapy, immunotherapy, and advanced radiotherapy techniques such as IMRT and SBRT. The survival rate for rectal cancer in Turkey is high, especially for early-stage diagnoses, thanks to precise diagnostics and personalized treatment plans. The five-year survival rate for rectal cancer in Turkey is approximately 71%, reflecting the country's commitment to providing quality cancer care.